ANDREA ROSATI: Open Payments
NPI 1336126630 · LEWISTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 18 payments from 8 companies in 2025. Trend: 2023 $589 · 2024 $537 · 2025 $465
Food & beverage: $397Education: $68
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $102 |
| Biogen, Inc. | 4 | $91 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Dexcom, Inc. | 3 | $74 |
| Amgen Inc. | 3 | $49 |
| Pharmacosmos Therapeutics Inc. | 1 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: ZURZUVAE, Dexcom G6 Transmitter, MYFEMBREE, EVENITY, MONOFERRIC, Veozah, GEMTESA, Lynkuet.
Industry payments across NY — which companies pay providers there.
